Skip to main content
. 2020 Aug 20;11:1799. doi: 10.3389/fimmu.2020.01799

Table 1.

General characteristics.

DEMOGRAPHICS
Total, No. (%) 105 (100)
Female, No. (%) 65 (61.9)
Age at onset, median (IQR), y 31 (25–46)
CLINICAL FEATURES
Phenotype, No. (%)
Optic neuritis 11 (10.5)
Myelopathy 51 (48.6)
Brainstem/Cerebellar syndrome 24 (22.9)
Hemispheric syndrome 4 (3.8)
Polyfocal 15 (14.3)
Fulfillment of DIS at baseline 42 (40%)
Patients with cranial MRI at baseline 105 (100)
Cranial MRI load (IQR) 3.5 (2–4)
Patients with spinal MRI at baseline 95 (90.5)
Spinal MRI load (IQR) 1 (0–2)
EDSS score at baseline (IQR) 2 (2–3)
PARACLINICAL FEATURES
CSF cell count (IQR) 9 (7–14)
CSF protein (IQR), mg/dl 35 (21–48)
OCB positivity, No. (%) 61 (58.1)
IgG index 0.64 (0.50–0.81)
IgG index elevation, No. (%) 44 (41.9)
FOLLOW-UP
CDMS at follow-up, No. (%) 69 (65.7)
McDonlad MS at follow-up, No. (%) 80 (76.2)
Time to CDMS (IQR), m 12 (5.5–27.5)
Follow-up duration (IQR), m 32 (23–67)

CDMS, clinically definite multiple sclerosis; CSF, cerebrospinal fluid; DIS, dissemination in space; EDSS, Expanded Disability Status Scale; IgG, immunoglobulin G; IQR, interquartile range; MRI, magnetic resonance imaging; OCB, oligoclonal band.